Vireo Growth (VREOF) Net Margin (2020 - 2026)

Vireo Growth's (VREOF) quarterly Net Margin came in at 21.19% in Q1 2026, up 534.0% year-on-year from 3.34% in Q1 2025, and up 34.45% quarter-over-quarter from 32.32% in Q4 2025.

Vireo Growth (VREOF) Net Margin (2020 - 2026) Analysis & Trends

Vireo Growth has disclosed Net Margin across 7 years of filings, most recently posting 21.19% for Q1 2026.

  • Net Margin for Q1 2026 came in at 21.19%, up 534.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 27.83% (up 3.0% YoY), and the FY2025 annual result was 30.33%, down 215.0% from the prior year.
  • Net Margin came in at 21.19% for Q1 2026 at Vireo Growth, up from 32.32% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 15.88% in Q4 2023 to a low of 113.07% in Q1 2022.
  • The 5-year median for Net Margin is 28.69% (2025), against an average of 32.43%.
  • Across the five-year window, Net Margin surged 8563 bps in 2022 and sank 7862 bps in 2024, its largest moves.
  • Vireo Growth's Net Margin stood at 17.54% in 2022, then soared by 191 bps to 15.88% in 2023, then slumped by 495 bps to 62.75% in 2024, then soared by 48 bps to 32.32% in 2025, then surged by 34 bps to 21.19% in 2026.
  • The last three Net Margin figures came in at 21.19% (Q1 2026), 32.32% (Q4 2025), and 28.69% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 9.19%
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 26.57%
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 35.18%
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 2.94%
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 24.30%
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 4.16%
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -168.42%
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -15.15%
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 31.38%
10 Vireo Growth - - 59.30 Mn -21.19%

Historic Data

Download Data
DateValue
Mar 31, 2026 -21.19%
Dec 31, 2025 -32.32%
Sep 30, 2025 -28.69%
Jun 30, 2025 -31.07%
Mar 31, 2025 -26.53%
Dec 31, 2024 -62.75%
Sep 30, 2024 -19.58%
Jun 30, 2024 -2.66%
Mar 31, 2024 -27.86%
Dec 31, 2023 15.88%
Sep 30, 2023 -23.22%
Jun 30, 2023 -36.59%
Mar 31, 2023 -44.37%
Dec 31, 2022 -17.54%
Sep 30, 2022 -50.78%
Jun 30, 2022 -28.94%
Mar 31, 2022 -113.07%
Dec 31, 2021 -103.17%
Sep 30, 2021 -51.16%
Jun 30, 2021 -49.10%